Eberling, J. L.

Safety and tolerability of putaminal AADC gene therapy for Parkinson disease

Christine, C. W., Starr, P. A., Larson, P. S., Eberling, J. L., Jagust, W. J., Hawkins, R. A., VanBrocklin, H. F., Wright, J. F., Bankiewicz, K. S., & Aminoff, M. J. (2009) · Neurology

Parkinson's Disease Mechanisms and TreatmentsVirus-based gene therapy research

Cited by 445

Results from a phase I safety trial of hAADC gene therapy for Parkinson disease

Eberling, J. L., Jagust, W. J., Christine, C. W., Starr, P., Larson, P., Bankiewicz, K. S., & Aminoff, M. J. (2008) · Neurology

Virus-based gene therapy researchParkinson's Disease Mechanisms and Treatments

Cited by 370

Eight Years of Clinical Improvement in MPTP-Lesioned Primates After Gene Therapy With AAV2-hAADC

Hadaczek, P., Eberling, J. L., Pivirotto, P., Bringas, J., Forsayeth, J., & Bankiewicz, K. S. (2010) · Molecular Therapy

Virus-based gene therapy researchParkinson's Disease Mechanisms and Treatments

Cited by 158

Functional imaging predicts cognitive decline in Alzheimer's disease.

Jagust, W. J., Haan, M. N., Eberling, J. L., Wolfe, N., & Reed, B. R. (1996) · Journal of Neuroimaging

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 39